Sectors

NRXP
NRx Pharmaceuticals, Inc.
4.46
5 x 4.44
1 x 4.47
bid
ask
-
0.00
0.11%
01:09 PM
timesize
Ytd64.39%
1y49.00%
4.35
day range
4.64
1.62
52 week range
5.05
Open4.41Prev Close4.46Low4.35High4.64Mkt Cap77.09M
Vol385.57KAvg Vol1.19MEPS-0.37P/E-12.05Forward P/E-1.12
Beta2.19Short Ratio4.80Inst. Own6.05%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg3.86200-d Avg2.771yr Est31.67

NRXP News

benzinga.com
NRx Pharmaceuticals Issues Statement In Response To Kadima Allegations, Citing Arbitration Over Non‑

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx" or the "Company") today issued the fo

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
globenewswire.com
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx”

benzinga.com
NRx Pharma’s HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navi

First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Sur

First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S

Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition
businesswire.com
Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Bre

SAN DIEGO--(BUSINESS WIRE)--Kadima Neuropsychiatry Institute and its founder, Dr. David Feifel, have

ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
prnewswire.com
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HO

SARASOTA, Fla, and BOSTON, June 23, 2026 /PRNewswire/ -- ZETA SURGICAL and HOPE Therapeutics, an NRx

benzinga.com
NRx Pharma Announces FDA Approval Of Intermediate Population Expanded Access Protocol For Use Of NRX

D-Cycloserine (DCS) has been reported to augment the effect of Transcranial Magnetic Stimulation (TM

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
globenewswire.com
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based N

WILMINGTON, Del., June 22, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biop

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
globenewswire.com
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nas

MIAMI, June 05, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq:NRXP, “the Company”) announces

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters' Option
globenewswire.com
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Inc

Offering was led by B Group Capital with significant participation from, among others, Columbia Thre

NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
globenewswire.com
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

WILMINGTON, Del., June 03, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx P

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

WILMINGTON, Del., June 02, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx P

NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validati

EMOCARE is a smartphone-based passive monitoring tool that generates a continuous, real-time measure

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Dep

Deployment at HOPE's West Palm Beach clinic brings AI-powered, sub-millimetric image guidance to the

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

My Top 3 Biotech Stocks for May 2026
fool.com
My Top 3 Biotech Stocks for May 2026

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, se

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty
seekingalpha.com
NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty

NRx Pharmaceuticals (NRXP) is downgraded from 'Buy' to 'Sell' following failures in ZYESAMI and NRX-

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
seekingalpha.com
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

NRx Pharmaceuticals Q1 Earnings Call Highlights
marketbeat.com
NRx Pharmaceuticals Q1 Earnings Call Highlights

NRx Pharmaceuticals NASDAQ: NRXP said it advanced several regulatory, manufacturing and clinical ini

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporat

Key highlights from the first quarter of operations under the expanded management team include the f

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates
zacks.com
NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.04 per share versus the Zacks

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
feeds.benzinga.com
NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Ea

NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, w

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
benzinga.com
NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Ea

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) will release earnings for its first quarter before the openi

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
globenewswire.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide C

WILMINGTON, Del., May 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Ph

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
benzinga.com
NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism ar

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Earnings Scheduled For March 17, 2025

benzinga.com
Earnings Scheduled For August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

benzinga.com
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday's session saw 211 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 431 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

    Tuesday's session saw 729 companies set new 52-week lows.

benzinga.com
Mid-Afternoon Market Update: Nasdaq Jumps 375 Points; Imperial Petroleum Shares Drop

US stocks recorded gains on the final trading day of January, with the Nasdaq Composite surging more

benzinga.com
32 Stocks Moving In Monday's Mid-Day Session

Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Frida

benzinga.com
61 Biggest Movers From Yesterday

Gainers